Cyanotech Corporation

48 articles with Cyanotech Corporation

• Cyanotech® Corporation Launches BioAstin®

  10/1/2020

  Cyanotech® Corporation, (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health products, announces its launch of BioAstin® Hawaiian Astaxanthin® in a new delivery form, water dispersible powder, available in both 1% and 2% concentrations.

• Cyanotech Reports Financial Results for the Fourth Quarter and Fiscal Year 2020

  6/23/2020

  Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health products, announced financial results for the fourth quarter and fiscal year 2020, ended March 31, 2020. Fiscal Year 2020 Cyanotech reported net sales of $31,899,000 for fiscal 2020 compared to $30,202,000 in fiscal 2019. Gross profit was $12,700,000, with gross profit margin of 39.8%,

• Cyanotech® Donates Protein Powder and Medical Supplies to Local Hospitals

  4/11/2020

  Cyanotech®,, a world leader in microalgae-based, high-value nutrition and health products, has donated over 700 bottles of their Hawaiian Spirulina® Protein Shake and personal protective equipment to two Hawaii Island hospitals.

• Cyanotech Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2020

  2/11/2020

  Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health products, announced financial results for the third quarter and first nine months of fiscal year 2020, ended December 31, 2019.

• Cyanotech Reports Financial Results for the Second Quarter and First Six Months of Fiscal 2020

  11/12/2019

  Net sales increase 10.6% to $7,690,000, operating income was $409,000 for second quarter

• Cyanotech Reports Financial Results for the First Quarter of Fiscal 2020

  8/13/2019

  Net sales increase 13% to $8,071,000, operating income was $49,000

• Cyanotech Reports Financial Results for the Fourth Quarter and Fiscal Year 2019

  7/1/2019

  Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health products, announced financial results for the fourth quarter and fiscal year 2019, ended March 31, 2019.

• Cyanotech® Corporation Earns Blue Zones® Certification

  4/4/2019

  Cyanotech Corporation,, a world leader in microalgae-based, high-value nutrition and health products, is proud to announce that it has joined the Blue Zones Project ‘Ohana.

• Cyanotech Reports Financial Results for the Third Quarter and First Nine Months of Fiscal Year 2019

  2/13/2019

  Net Sales Increase 9.8% to Record $10,044,000

• Cyanotech Names Brian Orlopp as VP Finance & Chief Financial Officer

  1/9/2019

  Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health products, announced that Brian B. Orlopp has been appointed Vice President Finance and Administration, Chief Financial Officer and Secretary effective January 3, 2019.

• Cyanotech Reports Financial Results for the First Quarter of Fiscal Year 2019

  8/13/2018

  For the first quarter of fiscal 2019 compared to the first quarter of fiscal 2018, net sales were $7,145,000 compared to $8,809,000.

• Cyanotech To Hold Investor Broadcast On Friday, August 11, 2017

  8/7/2017

• Cyanotech Reports Financial Results For The Third Quarter And First Nine Months Of Fiscal Year 2017

  2/8/2017

• Cyanotech Names Nancy Katz As A Director

  10/26/2016

• Cyanotech Reports Financial Results For The First Quarter Of Fiscal Year 2017

  8/15/2016

• Cyanotech Names David Mulder As A Director

  5/23/2016

• Founder Gerry Cysewski, Ph.D., Named Interim President & CEO Of Cyanotech

  4/4/2016

• Cyanotech Reports Financial Results For The First Quarter Of Fiscal Year 2016

  8/7/2015

• Cyanotech Adds Astaxanthin Productivity Enhancement

  6/12/2015

• Cyanotech Reports Financial Results For The Second Quarter And First Half Of Fiscal Year 2015

  11/11/2014